Drugs / BNT411
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04101357 | Jun 2020 → Jan 2024 | small cell lung carcinoma | BioNTech SE | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT411 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04101357 ↗ |
| Action | Activate | “BNT411 is a toll-like receptor 7 (TLR7) agonist” NCT04101357 ↗ |
| Target | TLR7 | “BNT411 is a toll-like receptor 7 (TLR7) agonist” NCT04101357 ↗ |